国药股份：应收账款增加涉及多个因素

Core Viewpoint - The increase in accounts receivable for China National Pharmaceutical Group Corporation (国药股份) is attributed to multiple factors, including business expansion, sales growth, and management strategies aimed at optimizing accounts receivable structure [1] Group 1: Factors Contributing to Accounts Receivable Increase - The company's business scale expansion and sales revenue growth have led to a corresponding increase in total accounts receivable [1] - The company is managing a dynamic balance between collection cycles and factoring discount costs, which has resulted in a reduction of the factoring scale for accounts receivable financing [1] - The collection cycles are also related to the periodic payment behaviors of clients, with some clients typically concentrating their payments at year-end [1] Group 2: Management Strategies - The company is committed to optimizing accounts receivable management through enhanced customer credit assessments and improved collection processes [1] - Measures are in place to ensure timely recovery of accounts receivable [1]